The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes

NCT02762708 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Obesity

Interventions

PROCEDURE: Roux-en-Y Gastric Bypass (RYGB)
BEHAVIORAL: Caloric Restriction
DRUG: Exendin-9,39
DRUG: Normal Saline

Sponsor

Mayo Clinic